Drugs Under Development
- Elvitegravir (GS 9137 or JTK-303), licensed by Gilead Sciences from Japan Tobacco, is currently undergoing Phase 3 clinical trials. GS 9137 is a low-molecular-weight, highly selective integrase inhibitor that shares the core structure of quinolone antibiotics.
- MK-2048, a second generation integrase inhibitor, that appears to have a duration of action up to 4 times longer than raltegravir.
Read more about this topic: Integrase Inhibitor
Famous quotes containing the words drugs and/or development:
“If we became students of Malcolm X, we would not have young black men out there killing each other like they’re killing each other now. Young black men would not be impregnating young black women at the rate going on now. We’d not have the drugs we have now, or the alcoholism.”
—Spike Lee (b. 1956)
“The highest form of development is to govern one’s self.”
—Zerelda G. Wallace (1817–1901)